欧林生物股价跌5.04%创近一个月新低资金博弈加剧估值压力

智选洞察2025-07-07

欧林生物（688319）今日股价明显走低，截至14点15分，报15.46元/股，跌幅达5.04%，创近一个月以来新低，成交额7936万元，换手率1.23%。资金博弈加剧估值压力欧林生物近期股价波动与资金面高频切换密切相关。截至7月4日，主力资金连续两个交易日累计净流出662.9万元，反映机构对疫苗板块估值分歧加剧。2025年前三季度亏损707万元的业绩表现，叠加动态市盈率-233.56倍的估值压力...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2549557300?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-07 14:15","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2549557300","market":"sh","top_or_hot":-1,"title":"欧林生物股价跌5.04%创近一个月新低 资金博弈加剧估值压力","media":"智选洞察","content":"<div>\n<p>欧林生物（688319）今日股价明显走低，截至14点15分，报15.46元/股，跌幅达5.04%，创近一个月以来新低，成交额7936万元，换手率1.23%。资金博弈加剧估值压力欧林生物近期股价波动与资金面高频切换密切相关。截至7月4日，主力资金连续两个交易日累计净流出662.9万元，反映机构对疫苗板块估值分歧加剧。2025年前三季度亏损707万元的业绩表现，叠加动态市盈率-233.56倍的估值压力...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707141551a69a47fd&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>欧林生物股价跌5.04%创近一个月新低 资金博弈加剧估值压力</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n欧林生物股价跌5.04%创近一个月新低 资金博弈加剧估值压力\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-07 14:15 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707141551a69a47fd&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>欧林生物（688319）今日股价明显走低，截至14点15分，报15.46元/股，跌幅达5.04%，创近一个月以来新低，成交额7936万元，换手率1.23%。资金博弈加剧估值压力欧林生物近期股价波动与资金面高频切换密切相关。截至7月4日，主力资金连续两个交易日累计净流出662.9万元，反映机构对疫苗板块估值分歧加剧。2025年前三季度亏损707万元的业绩表现，叠加动态市盈率-233.56倍的估值压力...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707141551a69a47fd&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707141551a69a47fd&s=b","article_id":"2549557300","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707141551a69a47fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2549557300","pubTimestamp":1751868945,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"欧林生物今日股价明显走低，截至14点15分，报15.46元/股，跌幅达5.04%，创近一个月以来新低，成交额7936万元，换手率1.23%。资金博弈加剧估值压力欧林生物近期股价波动与资金面高频切换密切相关。研发突破与产能升级双轮驱动长期来看，欧林生物在创伤救治领域的技术壁垒为其构筑护城河，吸附破伤风疫苗市占率超90%，2025年一季度营收同比增长23.58%，亏损同比收窄72.79%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688319":"欧林生物","BK0239":"医药制造"},"translate_title":"Olin Biotech's stock price fell 5.04%, hitting a new low in nearly a month, and the capital game intensified valuation pressure","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688319":1},"content_text":"欧林生物（688319）今日股价明显走低，截至14点15分，报15.46元/股，跌幅达5.04%，创近一个月以来新低，成交额7936万元，换手率1.23%。资金博弈加剧估值压力欧林生物近期股价波动与资金面高频切换密切相关。截至7月4日，主力资金连续两个交易日累计净流出662.9万元，反映机构对疫苗板块估值分歧加剧。2025年前三季度亏损707万元的业绩表现，叠加动态市盈率-233.56倍的估值压力，促使部分资金选择兑现离场。从市场风格看，6月中证1000指数上涨4.62%，但医药板块相对滞涨，资金转向科技成长方向，加剧了板块内部分化。7月7日该股振幅达7%，换手率1.23%，显示多空双方仍在技术面展开激烈博弈。研发突破与产能升级双轮驱动长期来看，欧林生物在创伤救治领域的技术壁垒为其构筑护城河，吸附破伤风疫苗市占率超90%，2025年一季度营收同比增长23.58%，亏损同比收窄72.79%。生产基地升级募资1.75亿元，将提升规模化生产效率。重组金葡菌疫苗III期临床入组超5000例，研发管线进入关键兑现阶段。中信证券研报指出，若在研品种年内获批，公司估值逻辑或从单品驱动转向平台型企业，给予18个月目标价21.5元。但需警惕临床进展延迟及创新药行业政策波动，预计后市将呈现震荡上行与阶段性回调交替特征。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2549557300","isCrawlerRequest":true}

欧林生物股价跌5.04%创近一个月新低 资金博弈加剧估值压力

精彩评论

欧林生物股价跌5.04%创近一个月新低资金博弈加剧估值压力